Board Chairman:
Atle Brynestad
Board Members:
Inger Sandlie
Bente-Lill Bjerkelund Romøren
Erlend Bremertun Smeland
Ingar Pettersen
General Manager:
Jonas Einarsson
Subsidiary companies:
BIO-MEDISINSK INNOVASJON AS
DNAACOS AS
Largest shareholders:
N/A
Export Markets:
Africa, Asia, Australia & Oceania, Europe, North America, South America, South Asia, West Asia